Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.03
-0.28 (-5.27%)
At close: Jan 14, 2025, 4:00 PM
5.00
-0.03 (-0.60%)
After-hours: Jan 14, 2025, 5:00 PM EST
Protara Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for TARA stock have an average target of 22.67, with a low estimate of 20 and a high estimate of 25. The average target predicts an increase of 350.70% from the current stock price of 5.03.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 6, 2024.
Analyst Ratings
The average analyst rating for TARA stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +297.61% | Dec 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +357.26% | Dec 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +357.26% | Nov 14, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $30 → $25 | Buy | Maintains | $30 → $25 | +397.02% | Aug 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +357.26% | Aug 8, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.14
from -3.57
EPS Next Year
-3.33
from -3.14
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | 23.4M | |||
Avg | n/a | n/a | 7.6M | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -2.38 | -1.94 | -1.49 | |||
Avg | -3.14 | -3.33 | -2.33 | |||
Low | -5.24 | -5.83 | -2.87 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.